Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Stattin

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
International Journal of Cancer|April 6, 2001
Plasma prolactin and prostate cancer risk: A prospective studyP Stattin, S Rinaldi, U H Stenman, et al.
International Journal of Obesity (2005)|September 20, 2007
Components of the metabolic syndrome and colorectal cancer risk; a prospective studyT Stocks, A Lukanova, M Johansson, et al.
BMC Medicine|March 2, 2018
The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation studyV J Gnanapragasam, O Bratt, K Muir, et al.
The Journal of Clinical Endocrinology and Metabolism|March 10, 2001
Leptin is associated with increased prostate cancer risk: a nested case-referent studyP Stattin, S Söderberg, G Hallmans, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Modal DNA values and estramustine-binding protein (EMBP) as prognostic markers in prostatic cancerH Nordgren, S Nilsson, S Eklöv, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 29, 2003
Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controlsR Kaaks, A Lukanova, S Rinaldi, et al.
Journal of the National Cancer Institute|December 7, 2000
Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective studyP Stattin, A Bylund, S Rinaldi, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|November 17, 2001
A cross-sectional study of IGF-I determinants in womenA Lukanova, P Toniolo, A Akhmedkhanov, et al.
International Journal of Cancer|January 12, 2018
Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS studyR Arthur, R Williams, H Garmo, et al.
World Journal of Urology|August 8, 2019
Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journeyJ Stranne, E Axen, I Franck-Lissbrant, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
International Journal of Cancer|April 6, 2001
Plasma prolactin and prostate cancer risk: A prospective studyP Stattin, S Rinaldi, U H Stenman, et al.
International Journal of Obesity (2005)|September 20, 2007
Components of the metabolic syndrome and colorectal cancer risk; a prospective studyT Stocks, A Lukanova, M Johansson, et al.
BMC Medicine|March 2, 2018
The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation studyV J Gnanapragasam, O Bratt, K Muir, et al.
The Journal of Clinical Endocrinology and Metabolism|March 10, 2001
Leptin is associated with increased prostate cancer risk: a nested case-referent studyP Stattin, S Söderberg, G Hallmans, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Modal DNA values and estramustine-binding protein (EMBP) as prognostic markers in prostatic cancerH Nordgren, S Nilsson, S Eklöv, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 29, 2003
Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controlsR Kaaks, A Lukanova, S Rinaldi, et al.
Journal of the National Cancer Institute|December 7, 2000
Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective studyP Stattin, A Bylund, S Rinaldi, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|November 17, 2001
A cross-sectional study of IGF-I determinants in womenA Lukanova, P Toniolo, A Akhmedkhanov, et al.
International Journal of Cancer|January 12, 2018
Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS studyR Arthur, R Williams, H Garmo, et al.
World Journal of Urology|August 8, 2019
Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journeyJ Stranne, E Axen, I Franck-Lissbrant, et al.
Pageof 6